Yukako Domoto Selected Research

Yukako Domoto Research Topics

2	Hematuria 01/2022 - 04/2020
2	Proteinuria 01/2022 - 04/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2020
1	Carcinoma (Carcinomatosis) 01/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Histiocytic Sarcoma 08/2021
1	Cardiomyopathies (Cardiomyopathy) 03/2021
1	Disease Progression 03/2021
1	Muscular Diseases (Myopathy) 03/2021
1	Heart Failure 06/2020
1	Low Cardiac Output 06/2020
1	Cardiac Edema 06/2020
1	Fibrosis (Cirrhosis) 12/2019
1	Immunoglobulin G4-Related Disease 12/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2019

1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	CreatinineIBA 01/2022
1	Muramidase (Lysozyme)IBA 08/2021
1	Proteins (Proteins, Gene)FDA Link 03/2021
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 03/2021
1	DiureticsIBA 06/2020
1	Dobutamine FDA LinkGeneric 06/2020
1	pembrolizumabIBA 04/2020
1	Immunoglobulin G (IgG)IBA 12/2019
1	GlucocorticoidsIBA 12/2019
1	Poly Adenosine Diphosphate RiboseIBA 10/2019